{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,21]],"date-time":"2026-04-21T02:56:58Z","timestamp":1776740218728,"version":"3.51.2"},"reference-count":25,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2014,2,1]],"date-time":"2014-02-01T00:00:00Z","timestamp":1391212800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,2,1]],"date-time":"2014-02-01T00:00:00Z","timestamp":1391212800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"AIRC (Italian Agency for Research on Cancer)","award":["10491"],"award-info":[{"award-number":["10491"]}]},{"name":"Fondazione Veronesi"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinica Chimica Acta"],"published-print":{"date-parts":[[2014,2]]},"DOI":"10.1016\/j.cca.2013.10.022","type":"journal-article","created":{"date-parts":[[2013,11,21]],"date-time":"2013-11-21T12:49:38Z","timestamp":1385038178000},"page":"46-50","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"special_numbering":"C","title":["PCA3 score of 20 could improve prostate cancer detection: Results obtained on 734 Italian individuals"],"prefix":"10.1016","volume":"429","author":[{"given":"Ettore","family":"Capoluongo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carlo Federico","family":"Zambon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniela","family":"Basso","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stefania","family":"Boccia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sandro","family":"Rocchetti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emanuele","family":"Leoncini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sara","family":"Palumbo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrea","family":"Padoan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giuseppe","family":"Albino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Angelo","family":"Todaro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tommaso","family":"Prayer-Galetti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Filiberto","family":"Zattoni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cecilia","family":"Zuppi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mario","family":"Plebani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.cca.2013.10.022_bb0005","doi-asserted-by":"crossref","first-page":"804","DOI":"10.7326\/0003-4819-118-10-199305150-00008","article-title":"Prostate cancer: screening, diagnosis, and management","volume":"118","author":"Garnick","year":"1993","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.cca.2013.10.022_bb0010","doi-asserted-by":"crossref","first-page":"1650","DOI":"10.1002\/cncr.23373","article-title":"Active surveillance for early-stage prostate cancer: review of the current literature","volume":"112","author":"Dall'Era","year":"2008","journal-title":"Cancer"},{"key":"10.1016\/j.cca.2013.10.022_bb0015","doi-asserted-by":"crossref","first-page":"11320","DOI":"10.1056\/NEJMoa0810084","article-title":"Screening and prostate-cancer mortality in a randomized European study","volume":"360","author":"Schroder","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cca.2013.10.022_bb0020","first-page":"272","article-title":"Transrectal ultrasound (TRUS) and TRUS-biopsy accuracy in potential candidates for PRIAS active surveillance protocol","volume":"84","author":"Lacetera","year":"2012","journal-title":"Arch Ital Urol Androl"},{"key":"10.1016\/j.cca.2013.10.022_bb0025","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.eururo.2010.10.039","article-title":"European Association of Urology. EAU guidelines on prostate cancer. Part 1: screening, diagnosis, and treatment of clinically localised disease","volume":"59","author":"Heidenreich","year":"2011","journal-title":"Eur Urol"},{"key":"10.1016\/j.cca.2013.10.022_bb0030","first-page":"227","article-title":"PCA3 score accuracy in diagnosing prostate cancer at repeat biopsy: our experience in 177 patients","volume":"84","author":"Barbera","year":"2012","journal-title":"Arch Ital Urol Androl"},{"key":"10.1016\/j.cca.2013.10.022_bb0035","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.1016\/j.juro.2007.11.038","article-title":"PCA3: a molecular urine assay for predicting prostate biopsy outcome","volume":"179","author":"Deras","year":"2008","journal-title":"J Urol"},{"key":"10.1016\/j.cca.2013.10.022_bb0040","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1002\/pros.22538","article-title":"Use of PCA3 in detecting prostate cancer in initial and repeat prostate biopsy patients","volume":"73","author":"Goode","year":"2013","journal-title":"Prostate"},{"key":"10.1016\/j.cca.2013.10.022_bb0045","doi-asserted-by":"crossref","first-page":"2119","DOI":"10.1016\/j.juro.2011.01.075","article-title":"Clinical evaluation of the PCA3 assay in guiding initial biopsy decisions","volume":"185","author":"de la Taille","year":"2011","journal-title":"J Urol"},{"key":"10.1016\/j.cca.2013.10.022_bb0050","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1016\/j.eururo.2010.06.038","article-title":"External validation of urinary PCA3-based nomograms to individually predict prostate biopsy outcome","volume":"58","author":"Auprich","year":"2010","journal-title":"Eur Urol"},{"key":"10.1016\/j.cca.2013.10.022_bb0055","doi-asserted-by":"crossref","first-page":"1947","DOI":"10.1016\/j.juro.2010.06.098","article-title":"PCA3 molecular urine test for predicting repeat prostate biopsy outcome in populations at risk: validation in the placebo arm of the dutasteride REDUCE trial","volume":"184","author":"Aubin","year":"2010","journal-title":"J Urol"},{"key":"10.1016\/j.cca.2013.10.022_bb0060","first-page":"553","article-title":"Predicting prostate biopsy outcome using a PCA3-based nomogram in a Polish cohort","volume":"33","author":"Salagierski","year":"2013","journal-title":"Anticancer Res"},{"key":"10.1016\/j.cca.2013.10.022_bb0065","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1097\/MOU.0b013e328344939c","article-title":"Contemporary role of prostate cancer gene 3 in the management of prostate cancer","volume":"21","author":"Roobol","year":"2011","journal-title":"Curr Opin Urol"},{"key":"10.1016\/j.cca.2013.10.022_bb0070","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/j.eururo.2010.06.039","article-title":"Performance of the prostate cancer antigen 3 (PCA3) gene and prostate-specific antigen in prescreened men: exploring the value of PCA3 for a first-line diagnostic test","volume":"58","author":"Roobol","year":"2010","journal-title":"Eur Urol"},{"key":"10.1016\/j.cca.2013.10.022_bb0075","doi-asserted-by":"crossref","DOI":"10.1016\/j.juro.2013.02.005","article-title":"Comparative effectiveness review: prostate cancer antigen 3 (PCA3) testing for the diagnosis and management of prostate cancer","author":"Bradley","year":"2013","journal-title":"J Urol"},{"key":"10.1016\/j.cca.2013.10.022_bb0080","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1590\/S1677-55382012000400008","article-title":"PCA3 score and prostate cancer diagnosis at repeated saturation biopsy. Which cut-off: 20 or 35?","volume":"38","author":"Pepe","year":"2012","journal-title":"Int Braz J Urol"},{"key":"10.1016\/j.cca.2013.10.022_bb0085","doi-asserted-by":"crossref","DOI":"10.1016\/j.juro.2013.02.018","article-title":"PCA3 molecular urine test as a predictor of repeat prostate biopsy outcome in men with previous negative biopsies: a prospective multicenter clinical study","author":"Gittelman","year":"2013","journal-title":"J Urol"},{"key":"10.1016\/j.cca.2013.10.022_bb0090","first-page":"4445","article-title":"PCA3 score vs PSA free\/total accuracy in prostate cancer diagnosis at repeat saturation biopsy","volume":"31","author":"Pepe","year":"2011","journal-title":"Anticancer Res"},{"key":"10.1016\/j.cca.2013.10.022_bb0095","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1002\/pros.22558","article-title":"Relationship between prostate cancer gene 3 (PCA3) and characteristics of tumor aggressiveness","volume":"73","author":"Augustin","year":"2013","journal-title":"Prostate"},{"key":"10.1016\/j.cca.2013.10.022_bb0100","doi-asserted-by":"crossref","first-page":"11347","DOI":"10.3390\/ijms140611347","article-title":"Value of PCA3 to predict biopsy outcome and its potential role in selecting patients for multiparametric MRI","volume":"14","author":"Leyten","year":"2013","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.cca.2013.10.022_bb0105","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.eururo.2010.10.024","article-title":"Critical assessment of preoperative urinary prostate cancer antigen 3 on the accuracy of prostate cancer staging","volume":"59","author":"Auprich","year":"2011","journal-title":"Eur Urol"},{"key":"10.1016\/j.cca.2013.10.022_bb0110","doi-asserted-by":"crossref","first-page":"1804","DOI":"10.1016\/j.juro.2008.01.013","article-title":"Pca3 molecular urine assay correlates with prostate cancer tumor volume: Implication in selecting candidates for active surveillance","volume":"179","author":"Nakanishi","year":"2008","journal-title":"J Urol"},{"key":"10.1016\/j.cca.2013.10.022_bb0115","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1002\/pros.21032","article-title":"Predictive value of pca3 in urinary sediments in determining clinico-pathological characteristics of prostate cancer","volume":"70","author":"Hessels","year":"2010","journal-title":"Prostate"},{"key":"10.1016\/j.cca.2013.10.022_bb0120","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1016\/j.eururo.2010.11.044","article-title":"Prostate cancer antigen 3 score accurately predicts tumour volume and might help in selecting prostate cancer patients for active surveillance","volume":"59","author":"Ploussard","year":"2011","journal-title":"Eur Urol"},{"key":"10.1016\/j.cca.2013.10.022_bb0125","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1016\/j.cca.2012.04.017","article-title":"Predicting prostate biopsy outcome: prostate health index (phi) and prostate cancer antigen 3 (PCA3) are useful biomarkers","volume":"413","author":"Ferro","year":"2012","journal-title":"Clin Chim Acta"}],"container-title":["Clinica Chimica Acta"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009898113004312?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009898113004312?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,14]],"date-time":"2025-09-14T14:45:18Z","timestamp":1757861118000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0009898113004312"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,2]]},"references-count":25,"alternative-id":["S0009898113004312"],"URL":"https:\/\/doi.org\/10.1016\/j.cca.2013.10.022","relation":{},"ISSN":["0009-8981"],"issn-type":[{"value":"0009-8981","type":"print"}],"subject":[],"published":{"date-parts":[[2014,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"PCA3 score of 20 could improve prostate cancer detection: Results obtained on 734 Italian individuals","name":"articletitle","label":"Article Title"},{"value":"Clinica Chimica Acta","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cca.2013.10.022","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}